Tuesday, 02 January 2024 12:17 GMT

Tobacco Alternative Gums Analysis Report 2026-2035: A $4.25 Billion Market By 2030 With CVS Health, The Kroger Co., Walgreens Boots Alliance, Along With Pfizer, Johnson & Johnson Leading


(MENAFN- GlobeNewsWire - Nasdaq) The tobacco alternative gums market presents key opportunities due to rising awareness of smoking risks, innovative nicotine-free products, e-commerce expansion, and growing demand for discreet alternatives. Strategic partnerships, domestic manufacturing, and a supportive regulatory environment further enhance market potential.

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Tobacco Alternative Gums Market Report 2026" has been added to ResearchAndMarkets's offering.

The tobacco alternative gums market is experiencing robust growth, with projections indicating an increase from $3.09 billion in 2025 to $4.25 billion by 2030, at a CAGR of 6.4%. This surge is driven by a heightened focus on preventive healthcare, a growing demand for tobacco harm reduction products, and innovations in nicotine-free gums. Government-led anti-smoking initiatives, coupled with rising awareness of smoking-related health risks, are pivotal in this market expansion.

Key factors contributing to this growth include the availability of nicotine replacement products, expanded pharmacy retail networks, and enhanced e-commerce healthcare sales. The rise in urban stress levels has also led to an increased demand for discrete and smokeless tobacco alternatives, including flavored and herbal chewing gums. This trend aligns with the broader global push toward healthier lifestyles and the adoption of nicotine replacement therapies.

The increase in smoking-related diseases like COPD, expected to rise by 23% by 2050, further underlines the necessity of tobacco alternative products. Market leaders are strategically forging partnerships to foster innovation and widen market margins. An example is Ryze's collaboration with 100Days to penetrate the Indian market with tailored nicotine gum flavors.

In a strategic move, Dr. Reddy's Laboratories acquired significant NRT brands from Haleon Plc for $0.559 billion in September 2024. This acquisition boosts Dr. Reddy's position in the global consumer healthcare sector, expanding its range of over-the-counter products under renowned brands such as Nicotinell.

Major players in the tobacco alternative gums market include CVS Health Corporation, The Kroger Co., Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson, and Novartis AG. These entities are navigating through challenges posed by fluctuating global trade relations and tariffs, which have marginally impacted manufacturing costs due to higher prices for imported materials. Nonetheless, these tariffs have encouraged local manufacturing and formulation innovation, contributing to long-term supply chain stability.

The market is segmented into 2 mg and 4 mg nicotine gums, among others, and distributed through diverse channels like pharmacies and online retailers. North America was the predominant region in 2025, while the report covers regions including Asia-Pacific, Western and Eastern Europe, South America, and the Middle East, with countries such as the USA, UK, China, and India leading in market share.

Additional product offerings in this market extend to caffeine, xylitol, ginseng, and vitamin-infused gums. The market assessments include 'factory gate' values, reflecting the revenues directly from manufacturers or creators to various entities or end customers, excluding resales.

This detailed analysis provides a comprehensive understanding of current market dynamics and future projections, essential for stakeholders aiming to thrive in the evolving tobacco alternative gums industry.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 - 2030
Estimated Market Value (USD) in 2026 $3.31 Billion
Forecasted Market Value (USD) by 2030 $4.25 Billion
Compound Annual Growth Rate 6.4%
Regions Covered Global


Companies Featured

  • CVS Health Corporation
  • The Kroger Co.
  • Walgreens Boots Alliance Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Philip Morris International Inc
  • Rite Aid Corporation
  • Meijer Inc
  • Reynolds American Incorporated
  • Perrigo Company plc
  • Perfetti Van Melle
  • Dr Reddy's Laboratories Ltd
  • Cipla Inc
  • Cambrex Corporation
  • Fertin Pharma A/S
  • Alchem International Pvt Ltd
  • CBD Chewing Gum UK
  • Jakes Mint Chew
  • Lucy Goods
  • Per Os Biosciences LLC
  • Smokey Mountain Chew Inc
  • Just Chew LLC

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Tobacco Alternative Gums Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20022026004107003653ID1110767434



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search